Patent · US Active

Prodrugs of A2B adenosine receptor antagonists

US7625881B2 · kind B2 · utility

18Cited by

12References

17Claims

0Family size

Assignee

Gilead Palo Alto, Inc. · US

Inventors

Rao V. Kalla · Cupertino, US
Dmitry Koltun · Foster City, US
Jeff Zablocki · Mountain View, US
Elfatih Elzein · Fremont, US

Key dates

Filing date	Jun 14, 2006
Grant date	Dec 1, 2009
Priority date	—
Expiry date	Sep 16, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D473/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are prodrugs of A2B adenosine receptor antagonists, having the following structureand their use in treating mammals for various disease states.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.